What Ocean Genomics does

Ocean Genomics, operating commercially as Ellumigen, is a Pittsburgh-based AI-native bioinformatics infrastructure company founded in 2021. Its core product, Ellumigen Explorer, is a unified platform that ingests raw sequencing files, routes them through distributed multi-omic pipelines (RNA-seq, DNA-seq, miRNA-seq, and NanoString Spatial Transcriptomics), and stores the resulting structured features in a high-performance database. The platform's differentiation rests on an LLM-powered natural language chat interface that lets scientific teams run differential expression and gene set enrichment analyses, generate publication-ready plots, and export sessions as Python notebooks, alongside standard APIs for downstream analytics and AI model development. The company reports over 150,000 samples processed through the platform.

Ellumigen serves bioinformatics and scientific teams within biotech, pharmaceutical, and academic research organizations, with explicit positioning around drug target identification, mechanism-of-action clarification, indication selection, and cancer genomics use cases. The business model is an enterprise SaaS subscription with quote-based pricing and annual billing cadence; a self-serve demo at explorer.ellumigen.ai serves as the primary inbound conversion point. Distribution combines self-serve evaluation for smaller users with an implied direct enterprise sales motion for larger biotech and pharma accounts.

The company has secured grant funding from the BIRD Foundation (in collaboration with Geneyx for cancer multi-omic software development) and investment from Accenture Ventures. Leadership comprises founder and CEO Carl Kingsford, CTO and co-founder Robert Patro, and co-founder and strategic advisor Eric V. Schultz. The company rebranded from Ocean Genomics to Ellumigen around July 2023 and operates as a privately held entity with no disclosed institutional venture round.

Name

Ocean Genomics

Legal name

Ellumigen

Website

https://oceangenomics.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Ocean Genomics, operating as Ellumigen, is a Pittsburgh-based AI-native bioinformatics company offering the Ellumigen Explorer platform for RNA-seq, DNA-seq, miRNA-seq, and spatial transcriptomics analysis, serving biotech, pharma, and academic research teams via enterprise SaaS subscriptions.

Ownership category

akta.pro rank

Product category

Bioinformatics Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)

SIC

Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

Keywords

• Bioinformatics analysis
• Sequencing analytics
• Multi-omic pipelines
• RNA-seq analysis
• Gene expression analytics

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Platform SaaS Subscription: AI-native bioinformatics platform offered as a subscription service with capabilities for sequencing analysis, study data management, and AI-guided workflows. Implied recurring revenue model based on platform access and usage.

Pricing tiers

Distribution channels2 records

Marketing channels4 records

Core offering

Ocean Genomics (operating as Ellumigen) provides an AI-native bioinformatics platform called Ellumigen Explorer that converts raw sequencing files into structured, biologically meaningful features through distributed multi-omic pipelines for RNA-seq, DNA-seq, miRNA-seq, and NanoString Spatial Transcriptomics. The platform combines LLM-powered natural language chat, a bioinformatics workbench, and APIs to support scientific teams with sequencing analysis, differential expression, gene set enrichment, and publication-ready outputs.

Product overview

Ocean Genomics offers Ellumigen Explorer™ as a unified AI-native bioinformatics platform for sequencing analysis. The platform provides end-to-end capabilities including raw file upload, distributed multi-omic pipeline transformation (RNA-seq, DNA-seq, miRNA-seq, NanoString Spatial Transcriptomics), and AI-guided data exploration via LLM-powered chat interface. The system stores processed data in a high-performance database and enables scientists to generate publication-ready outputs, export sessions as Python notebooks, and access data through APIs for downstream analytics.

Differentiator

Problem solved

Functional benefit

Brands

• Ellumigen Explorer™: AI-native analysis platform for sequencing and study data, enabling upload, transformation, and exploration of multi-omic data with LLM-powered chat interface and bioinformatics workbench.

Products and services

• Ellumigen Explorer™ AI-native bioinformatics platform that ingests raw sequencing files and curated study data, runs distributed multi-omic pipelines for RNA-seq, DNA-seq, miRNA-seq, and NanoString Spatial Transcriptomics, and exposes the processed data through an LLM-powered natural language chat interface, a Python notebook workbench, and APIs for downstream analytics. Built for scientific teams, biotech, and pharma research organizations running preclinical, clinical, and real-world evidence programs.

Quantifiable outcome

• 150,000+ samples processed through the platform
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

One partnership is on record.

• GeneyxcoreStrategic or Co-development Partner · 26 July 2023Joint collaboration with Geneyx to develop multi-omic software combining DNA and RNA analysis for improved genomic variant detection, disease diagnosis, and drug target identification. The partnership focuses on enhancing sensitivity and specificity in detecting structural variants, particularly in cancer applications, with potential to revolutionize personalized medicine and genomic diagnostics.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Emerging players

• BC Platforms: BC Platforms offers genomics and clinical data management plus analysis infrastructure for pharma and healthcare. It is an emerging peer in translational and clinical genomics data platforms.
• Form Bio: Form Bio provides a computational platform for life sciences data including genomics workflows. It is an emerging player in multi-omic data analysis competing for biotech and translational research customers.
• PlaidAI: PlaidAI is an AI-native bioinformatics platform focused on transcriptomics and multi-omic analysis with conversational interfaces. It is an emerging peer most directly comparable to Ellumigen's AI-native approach.
• Geneyx: Geneyx is an emerging AI-driven genomics analysis platform with a strategic partnership with Ocean Genomics/Ellumigen. It overlaps on DNA/RNA multi-omic analysis and cancer variant detection.

Direct peers

• DNAnexus: DNAnexus provides a cloud-based genomics data analysis and management platform used by pharma and clinical labs. It overlaps with Ellumigen on cloud bioinformatics infrastructure and enterprise sequencing workflows.
• Velsera (formerly Seven Bridges): Velsera operates a genomics data and analytics platform serving pharma, clinical, and research customers. It is a direct peer in cloud-based multi-omic analysis infrastructure.
• Partek (Partek Flow): Partek Flow is a commercial bioinformatics software platform supporting RNA-seq, DNA-seq, and single-cell analyses with a graphical interface. It is one of the closest direct competitors to Ellumigen Explorer's multi-omic analysis capabilities.
• Rosalind (formerly OnRamp Bio): Rosalind offers a cloud-based bioinformatics platform with collaboration features for RNA-seq and other omics data. It targets the same scientific teams segment as Ellumigen Explorer.

Broad incumbents

• Illumina (BaseSpace Sequence Hub): Illumina's BaseSpace is a cloud-based sequencing analysis and data management platform tightly integrated with Illumina sequencers. It competes with Ellumigen for sequencing workflow share among core genomics customers.
• QIAGEN Digital Insights (CLC Genomics Workbench): QIAGEN's CLC Genomics Workbench is an established desktop and server bioinformatics suite widely used in pharma, biotech, and academic labs. It is a broad incumbent competing across RNA-seq, DNA-seq, and variant analysis workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Ocean_Genomics
• LinkedInlinkedin.com/company/ocean-genomics

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ocean Genomics